Skip to content

The Effect of Local Colchicine gel on Actinic Keratosis Lesions

A Comparative study of the effect of 1% Local Colchicine gel and 3% Diclofenac Gel on Actinic Keratosis Lesions Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015040721645N1
Enrollment
70
Registered
2015-06-27
Start date
2013-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic keratosis. Actinic keratosis

Interventions

Intervention 1: Treatment by 1% colchicine gel twice a day. Intervention 2: Treatment by 3% diclofenac gel twice a day.
Treatment - Drugs
Treatment by 1% colchicine gel twice a day
Treatment by 3% diclofenac gel twice a day

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: sensitivity to Colchicine and diclofenac; consent of the individual to participate in the study. Exclusion criteria: If the patients were not interested in participating in the study; death; emigration; use of other treatment methods during the study period.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Treatment of cutaneous surface. Timepoint: The end of the first week, first month, second month and fourth month. Method of measurement: Dermatology ruler and Physical examination.;Patient satisfaction. Timepoint: Before and after intervention. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Adverse effects. Timepoint: The end of the first week, first month, second month and fourth month. Method of measurement: Ask the patient and Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGita Faghihi

Isfahan University of Medical Sciences

g_faghihi@med.mui.ac.ir+98 31 3668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026